C. Yelnik

Anticoagulation withdrawal in antiphospholipid syndrome: a retrospective matched-control study

A. Duhamel, E. Hachulla, É. Drumez, 2018, Lupus.

Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome

N. Costedoat-Chalumeau, V. Guern, E. Hachulla, 2018, Lupus.

Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity

A. Duhamel, E. Hachulla, É. Drumez, 2017, Lupus.

ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID study

L. Dauchet, A. Meirhaeghe, K. Faure, 2020, medRxiv.

CMI editorial report 2012.

D. Raoult, C. Yelnik, V. Emmans, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Raising rare disease awareness using red flags, role play simulation and patient educators: results of a novel educational workshop on Raynaud phenomenon and systemic sclerosis

E. Hachulla, D. Launay, M. Lambert, 2020, Orphanet Journal of Rare Diseases.

French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.

T. Lecompte, N. Costedoat-Chalumeau, D. Lasne, 2023, La Revue de medecine interne.